Peptide innovator says the drug class is due for a rethink
The FDA’s acceptance of several untested peptides for human use has left one drug innovator calling for a greater clarity…
Features
MSD’s Lipfendra takes on injectable rivals for cholesterol-lowering market supremacy
MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones
A strategic shift for gene therapies: manufacturing and market size take centre stage
Health tech’s role in obesity to expand beyond a ‘nice-to-have’
Orexin receptor agonists set to propel narcolepsy treatment into a new era
Boosting CGT access: a global consideration with wide-spanning benefits
Magazine: Made in the USA
